Literature DB >> 15661370

Expression of neural connexins and pannexin1 in the hippocampus and inferior olive: a quantitative approach.

Svenja Weickert1, Arundhati Ray, Georg Zoidl, Rolf Dermietzel.   

Abstract

Electrical synapses (or neuronal gap junctions) are thought to be essential for the generation of synchronous oscillatory activities in various areas of the brain. In this study, we quantified the steady state mRNA expression levels of two neuronal gap junction proteins, connexin36 (Cx36) and connexin45 (Cx45), as well as of pannexin1, a member of a novel class of communicative junction forming proteins, and of connexin47 (Cx47) which is expressed in oligodendrocytes. The expression levels of these genes were compared in two regions known for oscillatory activity and which are equipped with electrically coupled neurons. Assessment of the levels of mRNA expression in the hippocampus and the nuclear complex of the inferior olive (IO) was achieved by means of laser microdissection (LMM) in combination with real time RT-PCR. Our results demonstrate the differential expression of Cx36, Cx45, pannexin1 and Cx47 in the hippocampus, with pannexin1 showing the highest level of expression followed by Cx36, Cx47, and Cx45. In the IO, pannexin1 showed a comparable expression level as in the hippocampus, but connexin expression levels were increased. Upon direct comparison, the combination of LMM and real time RT-PCR data generated specific, robust and reproducible results consistent with recent data reported about connexin expression in the nervous system. We conclude that the analytical strategy shown here provides a technological solution to overcome the less sensitive and notoriously less specific analysis of connexin expression by in situ hybridization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661370     DOI: 10.1016/j.molbrainres.2004.09.026

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  15 in total

1.  Pannexin protein expression in the rat middle cerebral artery.

Authors:  Alan R Burns; Sharon C Phillips; Elke M Sokoya
Journal:  J Vasc Res       Date:  2012-02-01       Impact factor: 1.934

Review 2.  Pannexin expression in the cerebellum.

Authors:  Arundhati Ray; Georg Zoidl; Petra Wahle; Rolf Dermietzel
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

Review 3.  Connexins and pannexins: At the junction of neuro-glial homeostasis & disease.

Authors:  Andrew S Lapato; Seema K Tiwari-Woodruff
Journal:  J Neurosci Res       Date:  2017-06-05       Impact factor: 4.164

Review 4.  Brain Disorders and Chemical Pollutants: A Gap Junction Link?

Authors:  Marc Mesnil; Norah Defamie; Christian Naus; Denis Sarrouilhe
Journal:  Biomolecules       Date:  2020-12-31

Review 5.  Interactions of Pannexin1 channels with purinergic and NMDA receptor channels.

Authors:  Shuo Li; Ivana Bjelobaba; Stanko S Stojilkovic
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-04-04       Impact factor: 3.747

6.  Is connexin36 critical for GABAergic hypersynchronization in the hippocampus?

Authors:  Michael Beaumont; Gianmaria Maccaferri
Journal:  J Physiol       Date:  2011-02-07       Impact factor: 5.182

7.  Identification and characterization of pannexin expression in the mammalian cochlea.

Authors:  Xiao-Hui Wang; Michele Streeter; Ying-Peng Liu; Hong-Bo Zhao
Journal:  J Comp Neurol       Date:  2009-01-20       Impact factor: 3.215

8.  Architecture and development of olivocerebellar circuit topography.

Authors:  Stacey L Reeber; Joshua J White; Nicholas A George-Jones; Roy V Sillitoe
Journal:  Front Neural Circuits       Date:  2013-01-02       Impact factor: 3.492

Review 9.  Pannexin-1 Channels as Mediators of Neuroinflammation.

Authors:  Joon Ho Seo; Miloni S Dalal; Jorge E Contreras
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

10.  A comparative antibody analysis of pannexin1 expression in four rat brain regions reveals varying subcellular localizations.

Authors:  Angela C Cone; Cinzia Ambrosi; Eliana Scemes; Maryann E Martone; Gina E Sosinsky
Journal:  Front Pharmacol       Date:  2013-02-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.